semaglutide franklin tn in 61FIVE HEALTH & WELLNESS -
Description
Zepbound and Mounjaro are the brand names for Tirzepatide, which is a dual agonist affecting GLP-1 and glucose-dependent insulinotropic polypeptide (GIP for short)
For individuals taking these drugs to treat obesity, achieving weight loss targets may lead to intentional discontinuation
Ceasing Ozempic treatment may lead to weight regain
PlexusDx patients report discovering elevated cholesterol during routine lab work after starting semaglutide, only to see improvements in follow-up tests 812 weeks later
Which in turn leads to weight loss
